This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08724/identifier/chemspider/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08724/identifier/pdb/
n5http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08724/identifier/drugbank/

Statements

Subject Item
n2:DB08724
rdf:type
n6:Drug
n6:description
5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. This medication is known to target genome polyprotein.
n6:group
experimental
owl:sameAs
n5:DB08724 n12:DB08724
dcterms:title
5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole
adms:identifier
n9:W56 n10:4451504 n11:DB08724
n6:IUPAC-Name
n7:271B4DAB-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B4DB1-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B4DB0-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B4DAD-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B4DAE-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B4DAF-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B4DA9-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B4DA7-363D-11E5-9242-09173F13E4C5 n7:271B4DAA-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B4DA8-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B4DB7-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B4DB8-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B4DB2-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B4DB3-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B4DB5-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B4DB4-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B4DB6-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B4DBC-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B4DBE-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B4DBF-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B4DBB-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B4DBA-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B4DBD-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B4DAC-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B4DB9-363D-11E5-9242-09173F13E4C5